Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-1.75%
↑ 62% vs avg
Percentile
P64
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
-4.67%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -1.75% |
| Q3 2025 | 16.43% |
| Q2 2025 | 45.48% |
| Q1 2025 | 14.50% |
| Q4 2024 | -19.72% |
| Q3 2024 | 35.27% |
| Q2 2024 | -5.82% |
| Q1 2024 | -35.70% |
| Q4 2023 | -13.82% |
| Q3 2023 | -15.08% |
| Q2 2023 | -4.82% |
| Q1 2023 | 4.59% |
| Q4 2022 | -7.26% |
| Q3 2022 | -20.45% |
| Q2 2022 | -14.97% |
| Q1 2022 | -9.25% |
| Q4 2021 | 27.86% |
| Q3 2021 | 6.55% |
| Q2 2021 | -44.84% |
| Q1 2021 | -22.30% |
| Q4 2020 | -10.96% |
| Q3 2020 | -13.54% |
| Q2 2020 | 12.44% |
| Q1 2020 | -31.10% |
| Q4 2019 | 24.26% |
| Q3 2019 | -33.24% |
| Q2 2019 | 5.64% |
| Q1 2019 | 9.77% |
| Q4 2018 | -5.33% |
| Q3 2018 | -16.63% |
| Q2 2018 | 20.09% |
| Q1 2018 | -12.72% |
| Q4 2017 | -9.99% |
| Q3 2017 | 11.94% |
| Q2 2017 | 4.45% |
| Q1 2017 | -26.41% |
| Q4 2016 | -9.08% |
| Q3 2016 | -16.20% |
| Q2 2016 | -4.82% |
| Q1 2016 | -20.17% |